Acknowledgement
The first author, Warisraporn Tangchang, would like to express her gratitude for the financial support of the NVI Thailand and Naresuan University in Thailand.
References
- Bettini G, Marconato L, Morini M, Ferrari F. Thyroid transcription factor-1 immunohistochemistry: diagnostic tool and malignancy marker in canine malignant lung tumours. Vet Comp Oncol. 2009;7(1):28-37. https://doi.org/10.1111/j.1476-5829.2008.00166.x
- Moulton JE, von Tscharner C, Schneider R. Classification of lung carcinomas in the dog and cat. Vet Pathol. 1981;18(4):513-528.
- Wilson DW. Tumors of the respiratory tract. In: Donald JM, editor. Tumors in Domestic Animals. 5th ed. Wiley Online Library; 2016, 467-498.
- Jung J. Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol Res. 2014;30(1):1-5. https://doi.org/10.5487/TR.2014.30.1.001
- Hidalgo M, Amant F, Biankin AV, Budinska E, Byrne AT, Caldas C, et al. Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov. 2014;4(9):998-1013. https://doi.org/10.1158/2159-8290.CD-14-0001
- Lai Y, Wei X, Lin S, Qin L, Cheng L, Li P. Current status and perspectives of patient-derived xenograft models in cancer research. J Hematol Oncol. 2017;10(1):106.
- D'Costa S, Yoon BI, Kim DY, Motsinger-Reif AA, Williams M, Kim Y. Morphologic and molecular analysis of 39 spontaneous feline pulmonary carcinomas. Vet Pathol. 2012;49(6):971-978. https://doi.org/10.1177/0300985811419529
- Wu J, Chu PG, Jiang Z, Lau SK. Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study. Am J Clin Pathol. 2013;139(2):160-166. https://doi.org/10.1309/AJCP62WJUAMSZCOM
- Grossman DA, Hiti AL, McNiel EA, Ye Y, Alpaugh ML, Barsky SH. Comparative oncological studies of feline bronchioloalveolar lung carcinoma, its derived cell line and xenograft. Cancer Res 2002;62(13):3826-3833.
- Beck J, Miller MA, Frank C, DuSold D, Ramos-Vara JA. Surfactant protein A and Napsin A in the immunohistochemical characterization of canine pulmonary carcinomas: comparison with thyroid transcription factor-1. Vet Pathol. 2017;54(5):767-774. https://doi.org/10.1177/0300985817712559
- Uzaslan E, Stuempel T, Ebsen M, Freudenberg N, Nakamura S, Costabel U, et al. Surfactant protein A detection in primary pulmonary adenocarcinoma without bronchioloalveolar pattern. Respiration. 2005;72(3):249-253. https://doi.org/10.1159/000085365
- Hardavella G, George R, Sethi T. Lung cancer stem cells-characteristics, phenotype. Transl Lung Cancer Res. 2016;5(3):272-279. https://doi.org/10.21037/tlcr.2016.02.01
- Takeaki M, Takashi Y, Tetsuya S, Tsunehiro O, Hidetaka U, Toshihiro O, et al. Cancer stem cell markers in lung cancer. Personal Med Univ. 2015;4:40-45. https://doi.org/10.1016/j.pmu.2015.03.007
- Warth A, Cortis J, Soltermann A, Meister M, Budczies J, Stenzinger A, et al. Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. Br J Cancer. 2014;111(6):1222-1229. https://doi.org/10.1038/bjc.2014.402
- Griffey SM, Kraegel SA, Madewell BR. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts. J Comp Pathol. 1999;120(4):321-332. https://doi.org/10.1053/jcpa.1998.0281